Isaac Rice

Week in Review

Week in Review

The Supreme Court allows a New York gun law to remain in force, FDA approves new Alzheimer’s drug, and more…

Top Regulatory News of 2022

Top Regulatory News of 2022

The Regulatory Review highlights the top regulatory news and scholarship of 2021, as selected by our staff.

Week in Review

Week in Review

The U.S. Senate passes a bill to grant federal protection for same sex and interracial marriage, the U.S. House passes a bill to avoid a railroad strike, and more…

Week in Review

Week in Review

California votes to ban flavored tobacco products, Missouri legalizes recreational marijuana, and more…

Week in Review

Week in Review

Appeals court finds the CFPB’s structure unconstitutional, the FTC proposes civil penalties for impersonation, and more…

Week in Review

Week in Review

Appeals court finds banning for-profit prisons unconstitutional, President Biden announces agricultural initiatives, and more…

Week in Review

Week in Review

President Biden announces nominee to head OIRA, a federal judge blocks coverage of HIV prevention drugs, and more…

Week in Review

Week in Review

President Biden signs the Inflation Reduction Act of 2022, FDA allows over-the-counter sales of hearing aids, and more…

Week in Review

Week in Review

President Biden issues an executive order to protect reproductive health care access, New York State Supreme Court rules against the New York Department of Health’s quarantine procedures, and more…

Week in Review

Week in Review

The Supreme Court strikes down restrictions on concealed carry laws, FDA announces new limits on nicotine levels in tobacco products, and more…

Week in Review

Week in Review

The Supreme Court blocks a Texas law limiting the moderation of speech on social media, the Justice Department reviews the police response to the Uvalde shooting, and more…

Week in Review

Week in Review

The U.S. Department of Justice cracks down on ghost guns, President Biden announces the EPA will allow the sale of “E15” gasoline, and more…